Democritus University of Thrace (DUTH)
Παρακολούθηση με 24ωρη καταγραφή της αρτηριακής πίεσης ασθενών σε τελικό στάδιο νεφρικής ανεπάρκειας προ της ένταξής τους σε αιμοκάθαρση ή συνεχή φορητή περιτοναϊκή κάθαρση: έλεγχος πιθανών μεταβολών 3, 6, 12 μήνες μετά την ένταξη
Abstract
dc:descriptionOver the last years there has been a lot of discussion concerning the use of ambulatory blood pressure monitoring and its use in clinical practice. The advantages the ambulatory blood pressure monitoring has to offer has made it a useful tool in diagnosing and treating hypertension. The increased incidence of hypertension and vascular diseases a cause of end stage renal disease has made ABPM necessary in evaluating hypertension and other risk factors for renal disease. In hypertensive patients and type I diabetics, ABPM data usually have a stronger correlation with the presence and magnitude of microalbuminurria, than the routine office BP measurements. ABPM improved our knowledge of the circadian variability of arterial blood pressure. Many hypertensive patients fail to manifest the normal nocturnal fall of BP. They are being called nondippers, while those with a normal circadian rhythm are called dippers. Nocturnal blood pressure seems to be the best market for renal risk. Nondipping occurs in healthy overaged people >80 years as well as in patients with hypertension, diabetes, stroke nondipping is an independent risk factor for left ventricular hypertrophy. ABPM is indicated in screening for white coat hypertension, resistant to medication hypertension, hypotension in patients treated for hypertension, screening for nondipping or naturnal hypertension, difference in home measurements.Despite the fact that the major cause of death in these patients is cardiovascular diseases, there is still much controversy concerning the right time of measurement of BP in dialysis patients.We studied a cohort of 30 patients, of both sexes and of all ages, with end stage renal disease. The purpose of this study was:1.To the investigate the prevalence of nondippers before and after entering renal replacement therapy program.2.To find out if there is a decrease in the number of antihypertensive agents used after entering renal replacement therapy program.3.To investigate any correlation of nondipping with underlying diseases (as diabetes, coronary artery disease, metabolic syndrome, hypertension), the antihypertensive treatment, the efficiency of haemodialysis, as well as biochemical indicators.A 24-hour ambulatory blood pressure was measured for every patient before as well as 3, 6 and 12 months after beginning a renal replacement therapy program.A statistically significant decrease of patients with hypertension was observed over time, a significant increase of patients in need of lipid lowering agents and significant increase of patients with metabolic syndrome during the follow up of the patients.On the 3-month and 12-month measurements, nondipping patients on dialysis, remained nondippers the day after, whereas most of the dippers during the dialysis day appeared with nondipping pattern the next day.Patients with a stable circadian rhythm (either dippers or nondippers) seemed to have a decrease in antihypertensive drugs when measured at 3 and 12 months after renal replacement therapy.Of the patients studied, 16 remained nondippers during the study period, and they showed a significant decrease of antihypertensive drugs, from two, before beginning renal replacement therapy, to one at 3, 6 and 12 months, although the number of patients with hypertension did not significantly decrease.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vagiona, Argyri
- Βαγιωνά, Αργυρή
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28543